Comparing two treatments for trauma stress disorder

This trial is testing whether two medications taken together—reboxetine and methylphenidate—can help reduce symptoms of post-traumatic stress disorder (PTSD). The study compares this medication combination to dog-assisted therapy, where participants work with trained therapy dogs in group sessions. Researchers believe this medication pair may help improve attention, emotional processing, and sensory sensitivity that often trouble people with PTSD.

Current treatments for PTSD either require lots of specialized therapy sessions or are medications that don't work for everyone and often cause unwanted side effects. This trial exists because researchers have early evidence suggesting that this new medication combination may be safer, easier to tolerate, and more effective at addressing the specific brain changes linked to PTSD.